Riskpilot← Back to searchSign inGet full accessNETTAPOTEKET HOLDING AS
ASActiveOrg 923766197Haraldrudveien 11, 0581 OsloRetail sale of pharmaceutical products · NACE 4773Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
+95% vs 2023
Equity ratio
92.4%
Financial strength
Net profit 2024
NOK -5K
+95% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -5K | +95% |
| Net profit | NOK -5K | +95% |
| Total assets | NOK 15,4M | +0% |
| Equity | NOK 14,2M | +0% |
| Employees | 0 | — |
Legal name
NETTAPOTEKET HOLDING AS
Org number
923766197
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
7. november 2019
Share capital
NOK 2 274 630
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Apotekvirksomhet med eget utsalg og ved salg av apotekvarer via internett samt all vikrsomhet som står i forbindelse med dette, herunder det å eie aksjer i andre selskaper med samme formål eller selskaper i tilsvarende bransje.
Address
Haraldrudveien 11, 0581 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −2 184 | −9 058 | −32 | −93 | −5 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 184 | −9 058 | −32 | −93 | −5 |
| Net financials | −30 | −1 | 9 948 | 0 | 0 |
| Profit before tax | −2 214 | −9 059 | 9 916 | −93 | −5 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −2 214 | −9 059 | 9 916 | −93 | −5 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 601 | 79 | 15 561 | 15 370 | 15 359 |
| Equity | 590 | −1 068 | 14 291 | 14 198 | 14 193 |
| Long-term debt | 0 | 0 | 0 | 0 | 1 100 |
| Short-term debt | 10 | 1 147 | 1 270 | 1 172 | 66 |
| Total debt | 10 | 1 147 | 1 270 | 1 172 | 1 166 |
EBITDA margin
-493400.0%
This company
15.8%
Market median
-3122885% vs market
20202024
Equity ratio
92.4%
This company
38.2%
Market median
+142% vs market
20202024
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
-493400.0%
This company
8.1%
Market median
-6091458% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50.27% | 50.27% | 2024 | |
| Company | 22.36% | 22.36% | 2024 | |
Add Pharma Nordic Ab | Company | 9% | 9% | 2023 |
Addeira Pharmaceuticals Ab | Company | 9% | 9% | 2024 |
| Company | 4.09% | 4.09% | 2024 | |
| Company | 4% | 4% | 2024 | |
| Company | 3.51% | 3.51% | 2024 | |
| Individual | 1.85% | 1.85% | 2024 | |
| Individual | 1.85% | 1.85% | 2024 | |
| Company | 1.56% | 1.56% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NETTAPOTEKET HOLDING AS 
APOTERA.NO ASBoard members of NETTAPOTEKET HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristian Malm | Board of Directors | 0 companies |
| Lars Birkeland | Chairman | 0 companies |
| Patrick Hjetland | Board of Directors | 0 companies |